Integral Diagnostics Limited

Equities

IDX

AU000000IDX2

Healthcare Facilities & Services

Market Closed - Australian S.E. 02:10:52 2024-04-24 am EDT 5-day change 1st Jan Change
2.51 AUD -1.95% Intraday chart for Integral Diagnostics Limited +2.45% +31.76%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Morgan Stanley Adjusts Integral Diagnostics’ Price Target to AU$1.85 From AU$1.70, Keeps at Underweight MT
Jarden Research Adjusts Integral Diagnostics’ Price Target to AU$2.59 From AU$2.54, Keeps at Neutral MT
Integral Diagnostics Shares Gain 2%; Posts 7% Rise in H1 FY24 Revenue, Profit Slips MT
Transcript : Integral Diagnostics Limited, H1 2024 Earnings Call, Feb 20, 2024
Integral Diagnostics Reports H1 FY24 Revenue Up 7% to AU$231.3 Million; EPS of AU$0.031 MT
Integral Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
IDX? Announces Appointment of Scott Paterson as Worldwide CFO CI
Integral Diagnostics Limited Announces Change of Company Secretary CI
Integral Diagnostics Limited Announces Resignation of Helen Kurincic as Director Effective 29 November 2023 CI
Transcript : Integral Diagnostics Limited - Shareholder/Analyst Call
4DMedical Enters Agreement with Integral Diagnostics for XV Technology Distribution; Shares Jump 9% MT
Integral Diagnostics Announces Release of Certain Shares from Voluntary Escrow MT
Integral Diagnostics Appoints Chair Elect MT
Integral Diagnostics Limited Appoints Toby Hall as Director CI
Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Six Months Ended June 30, 2023, Payable on October 04, 2023 CI
Integral Diagnostics Raises Final Dividend as Fiscal 2023 Profit Rises MT
Transcript : Integral Diagnostics Limited, 2023 Earnings Call, Aug 28, 2023
Integral Diagnostics Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Integral Diagnostics Limited Declares Fully Franked Final Dividend, Payable on October 04, 2023 CI
Integral Diagnostics Limited Announces Board Changes CI
Integral Diagnostics Discloses Release of Shares from Voluntary Escrow MT
Integral Diagnostics Discloses Release of Shares from Voluntary Escrow in July MT
Integral Diagnostics Grows Fiscal H1 Profit, Lowers Interim Dividend; Shares Down 16% MT
Transcript : Integral Diagnostics Limited, H1 2023 Earnings Call, Feb 17, 2023
Integral Diagnostics Limited Announces Ordinary Dividend for the Six Months Ended December 31, 2022, Payable on April 4, 2023 CI
Chart Integral Diagnostics Limited
More charts
Integral Diagnostics Limited is an Australia-based provider of medical imaging services across Australia and New Zealand. It provides diagnostic services to patients and their referrers across Australia and New Zealand. It operates brands in four Australian States: Lake Imaging in Victoria, the X-Ray Group in VIC/NSW, South Coast Radiology, Peloton Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. It also operates in New Zealand through the Astra Radiology, SRG Radiology, Horizon Radiology and Trinity MRI brands. Lake Imaging offers a private radiology service to patients throughout Central and Western Victoria. South Coast Radiology provides medical imaging services and patient care to the Gold Coast and Tweed Heads communities. Imaging Queensland is a provider of advanced diagnostic imaging services and radiology education across Queensland. Apex Radiology provides diagnostic imaging services for patients in rural and regional communities.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
2.56 AUD
Average target price
2.523 AUD
Spread / Average Target
-1.44%
Consensus